title: Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.
abstract: Neuropathy target esterase (NTE) is a phospholipase/lysophospholipase associated with organophosphorus (OP) compound-induced delayed neurotoxicity (OPIDN). Distal degeneration of motor axons occurs in both OPIDN and the hereditary spastic paraplegias (HSPs). Recently, mutations within the esterase domain of NTE were identified in patients with a novel type of HSP (SPG39) designated NTE-related motor neuron disease (NTE-MND). Two of these mutations, arginine 890 to histidine (R890H) and methionine 1012 to valine (M1012V), were created in human recombinant NTE catalytic domain (NEST) to measure possible changes in catalytic properties. These mutated enzymes had decreased specific activities for hydrolysis of the artificial substrate, phenyl valerate. In addition, the M1012V mutant exhibited a reduced bimolecular rate constant of inhibition (k(i)) for all three inhibitors tested: mipafox, diisopropylphosphorofluoridate, and chlorpyrifos oxon. Finally, while both mutated enzymes inhibited by OP compounds exhibited altered time-dependent loss of their ability to be reactivated by nucleophiles (aging), more pronounced effects were seen with the M1012V mutant. Taken together, the results from specific activity, inhibition, and aging experiments suggest that the mutations found in association with NTE-MND have functional correlates in altered enzymological properties of NTE.
authors.affiliation: Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2029, USA.
authors.forename: Nichole D
authors.initials: ND
authors.lastname: Hein
authors.forename: Jeanne A
authors.initials: JA
authors.lastname: Stuckey
authors.forename: Shirley R
authors.initials: SR
authors.lastname: Rainier
authors.forename: John K
authors.initials: JK
authors.lastname: Fink
authors.forename: Rudy J
authors.initials: RJ
authors.lastname: Richardson
mesh_terms: D002265:Carboxylic Ester Hydrolases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D020134:Catalytic Domain; D004390:Chlorpyrifos / Q000031:analogs & derivatives / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D006868:Hydrolysis; D007531:Isoflurophate / Q000031:analogs & derivatives / Q000494:pharmacology; D007700:Kinetics; D016472:Motor Neuron Disease / Q000201:enzymology* / Q000235:genetics; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D011994:Recombinant Proteins / Q000378:metabolism; D015419:Spastic Paraplegia, Hereditary / Q000201:enzymology* / Q000235:genetics; D013379:Substrate Specificity; D014631:Valerates / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D011994:Recombinant Proteins; D014631:Valerates; D007531:Isoflurophate; C049867:phenyl valerate; C005238:mipafox; C009618:O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate; D002265:Carboxylic Ester Hydrolases; C021859:neurotoxic esterase; D004390:Chlorpyrifos
references.citation: Mol Cell Biol. 2004 Feb;24(4):1667-79
references.pmid: 14749382
references.citation: BMC Neurosci. 2005 Feb 01;6:6
references.pmid: 15686598
references.citation: Biochim Biophys Acta. 1981 Aug 13;660(2):306-16
references.pmid: 7284405
references.citation: Biochem J. 1998 May 15;332 ( Pt 1):1-4
references.pmid: 9576844
references.citation: Protein J. 2007 Apr;26(3):165-72
references.pmid: 17216363
references.citation: Toxicol Appl Pharmacol. 1999 Feb 15;155(1):43-53
references.pmid: 10036217
references.citation: J Theor Biol. 2002 Sep 21;218(2):207-14
references.pmid: 12381293
references.citation: Fundam Appl Toxicol. 1997 Jul;38(1):55-63
references.pmid: 9268605
references.citation: Biochem J. 2003 Jul 1;373(Pt 1):33-40
references.pmid: 12665427
references.citation: Fundam Appl Toxicol. 1986 Apr;6(3):464-71
references.pmid: 3699331
references.citation: Arch Toxicol. 1977 Jun 18;37(2):113-5
references.pmid: 577680
references.citation: Cell Cycle. 2008 May 1;7(9):1157-60
references.pmid: 18418040
references.citation: Biochem J. 1969 Oct;114(4):711-7
references.pmid: 4310054
references.citation: Toxicol Lett. 1987 Apr;36(2):197-204
references.pmid: 3576651
references.citation: Toxicol Lett. 1998 Mar 31;95(2):93-101
references.pmid: 9635412
references.citation: J Toxicol Environ Health A. 2003 Jun 27;66(12):1145-57
references.pmid: 12791540
references.citation: Toxicol Rev. 2005;24(1):37-49
references.pmid: 16042503
references.citation: J Neurosci. 2009 Sep 16;29(37):11594-600
references.pmid: 19759306
references.citation: Biochem J. 1979 Feb 1;177(2):549-58
references.pmid: 435251
references.citation: Anal Chem. 2007 Jul 15;79(14):5196-203
references.pmid: 17555296
references.citation: Arch Toxicol. 1978 Dec 28;41(3):215-21
references.pmid: 736792
references.citation: Ann Oncol. 2009 Aug;20 Suppl 6:vi35-40
references.pmid: 19617296
references.citation: J Biol Chem. 2000 Aug 11;275(32):24477-83
references.pmid: 10816586
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7983-7
references.pmid: 12805562
references.citation: Fundam Appl Toxicol. 1993 Apr;20(3):273-9
references.pmid: 7684990
references.citation: Fundam Appl Toxicol. 1996 Mar;30(1):23-30
references.pmid: 8812209
references.citation: Biochemistry. 2004 Mar 30;43(12):3716-22
references.pmid: 15035642
references.citation: Am J Pathol. 1979 Feb;94(2):241-52
references.pmid: 426027
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5075-80
references.pmid: 15051870
references.citation: Toxicol Appl Pharmacol. 2008 Nov 1;232(3):376-83
references.pmid: 18706436
references.citation: Am J Hum Genet. 2008 Mar;82(3):780-5
references.pmid: 18313024
references.citation: Arch Toxicol. 1991;65(2):150-5
references.pmid: 1711837
references.citation: Toxicol Lett. 2006 Mar 15;162(1):94-7
references.pmid: 16309859
references.citation: J Biol Chem. 2004 Jun 4;279(23):24024-33
references.pmid: 15044461
references.citation: J Anal Toxicol. 1991 Mar-Apr;15(2):86-9
references.pmid: 2051750
references.citation: J Biol Chem. 2002 Jun 7;277(23):20942-8
references.pmid: 11927584
references.citation: J Neurosci. 2005 Mar 16;25(11):2865-73
references.pmid: 15772346